UBX

Unity Biotechnology
UBX

Overview Fund Activity
Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

84 hedge funds and large institutions have $42M invested in Unity Biotechnology in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 18 closing their positions.

Holders
84
Holders Change
-14
Holders Change %
-14.29%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
6
Increased
18
Reduced
28
Closed
18
Calls
$1.09M
Puts
$269K
Net Calls
+$816K
Net Calls Change
-$120K

Top Buyers

1
GCP
1
GSA Capital Partners
United Kingdom
$1.4M
2
BCM
2
Bridgeway Capital Management
Texas
$799K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$669K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.92M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$793K

Top Sellers

1
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$1.77M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.7M
3
Morgan Stanley
3
Morgan Stanley
New York
$1.5M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$1.63M
5
Millennium Management
5
Millennium Management
New York
$1.32M
Name Market Value Shares Shares
Change 		Shares
Change %
IA
101
IFP Advisors
Florida
– – – –
PA
102
Parallel Advisors
California
$0 10 – –
TF
103
TimeScale Financial
Massachusetts
$0 132 – –
LC
104
Lindbrook Capital
California
$0 40 – –
CFGS
105
Concourse Financial Group Securities
Alabama
– – – –
GKWIM
106
Gerber Kawasaki Wealth & Investment Management
California
$0 200 +200 New
1 2 3 4
5